Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.73 USD | -0.51% | +3.16% | -0.81% |
05-13 | Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed | MT |
05-10 | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.81% | 2.32B | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.99% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Morgan Stanley Lifts Price Target on Recursion Pharmaceuticals to $11 From $8 Amid NVIDIA Partnership, Keeps Equalweight Rating